Last $82.94 USD
Change Today +1.37 / 1.68%
Volume 216.2K
GWPH On Other Exchanges
Symbol
Exchange
London
OTC US
NASDAQ GM
Frankfurt
Stuttgart
As of 8:10 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

gw pharmaceuticals -adr (GWPH) Snapshot

Open
$81.69
Previous Close
$81.57
Day High
$83.99
Day Low
$81.63
52 Week High
07/1/14 - $111.46
52 Week Low
04/15/14 - $41.86
Market Cap
1.6B
Average Volume 10 Days
207.5K
EPS TTM
--
Shares Outstanding
19.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GW PHARMACEUTICALS -ADR (GWPH)

gw pharmaceuticals -adr (GWPH) Details

GW Pharmaceuticals plc, a biopharmaceutical company, together with its subsidiaries, engages in discovering, developing, and commercializing cannabinoid prescription medicines. It operates in three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company primarily offers Sativex, an oromucosal spray for the treatment of multiple sclerosis symptoms, cancer pain, and neuropathic pain. It also focuses on the Phase III clinical development program of Sativex for use in the treatment of cancer pain. In addition, the company’s product pipeline includes an orphan childhood epilepsy program, as well as other product candidates in Phase I and II clinical development for the treatment of glioma, ulcerative colitis, type-2 diabetes, and schizophrenia. It has a strategic alliance with Otsuka Pharmaceutical Co., Ltd. The company operates in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Salisbury, the United Kingdom.

294 Employees
Last Reported Date: 02/4/15
Founded in 1998

gw pharmaceuticals -adr (GWPH) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: 567.8K GBP
Founder, Executive Chairman and Chairman of N...
Total Annual Compensation: 696.1K GBP
Chief Financial Officer, Company Secretary an...
Total Annual Compensation: 389.8K GBP
Chief Operating Officer and Executive Directo...
Total Annual Compensation: 421.8K GBP
Research & Development Director and Executive...
Total Annual Compensation: 475.3K GBP
Compensation as of Fiscal Year 2014.

gw pharmaceuticals -adr (GWPH) Key Developments

GW Pharmaceuticals plc Presents at SunTrust Robinson Humphrey Biotechnology and Pharmaceutical One-on-One Orphan Drug Day, Feb-23-2015

GW Pharmaceuticals plc Presents at SunTrust Robinson Humphrey Biotechnology and Pharmaceutical One-on-One Orphan Drug Day, Feb-23-2015 . Venue: JW Marriott Essex House, 160 Central Park South, b/w 6th & 7th Avenue, New York, New York, United States.

GW Pharmaceuticals plc Reports Consolidated Earnings Results for the First Quarter Ended December 31, 2014

GW Pharmaceuticals plc reported consolidated earnings results for the first quarter ended December 31, 2014. For the quarter, the company reported revenue of £8.0 million ($12.4 million) compared to £7.5 million for the three months ended 31 December 2013. Loss was £3.4 million ($5.3 million) or 1.4 pence per basic and diluted share compared to £2.8 million 1.6 pence per basic and diluted share for the three months ended 31 December 2013. The company reported operating loss of £4.5 million compared to £3.5 million, loss before tax of £4.5 million compared to £3.5 million, net cash outflow from operating activities of £6.2 million compared to £2.4 million and purchases of property, plant and equipment of £5.9 million compared to £0.7 million for the last year.

GW Pharmaceuticals plc Presents at Leerink's Global Healthcare Conference, Feb-11-2015 03:30 PM

GW Pharmaceuticals plc Presents at Leerink's Global Healthcare Conference, Feb-11-2015 03:30 PM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Justin D. Gover, Chief Executive Officer, Managing Director and Executive Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GWPH:US $82.94 USD +1.37

GWPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cannabis Science Inc $0.05 USD 0.00
Medical Marijuana Inc $0.11 USD -0.0009
PharmaCyte Biotech Inc $0.10 USD +0.0005
View Industry Companies
 

Industry Analysis

GWPH

Industry Average

Valuation GWPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 33.3x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 33.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GW PHARMACEUTICALS -ADR, please visit www.gwpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.